Who owns the DAZUBLYS (TRASTUZUMAB) trademark?

The DAZUBLYS (TRASTUZUMAB) trademark is owned by CuraTeQ Biologics Private Limited.

What class is the DAZUBLYS (TRASTUZUMAB) trademark registered in?

The DAZUBLYS (TRASTUZUMAB) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DAZUBLYS (TRASTUZUMAB)?

The USPTO serial number for DAZUBLYS (TRASTUZUMAB) is 79395335.

What is the registration number for DAZUBLYS (TRASTUZUMAB)?

DAZUBLYS (TRASTUZUMAB) is registered under USPTO registration number 0.

DAZ

USPTO Trademark Record

ABANDONED

DAZUBLYS (TRASTUZUMAB)

SN 79395335·Reg 0·Filed Jan 29, 2024

Owner CuraTeQ Biologics Private Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DAZUBLYS (TRASTUZUMAB) (Serial No. 79395335), Registration No. 0, is a abandoned US trademark filed on Jan 29, 2024 by CuraTeQ Biologics Private Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

DAZUBLYS (TRASTUZUMAB) (Reg. #0) is an abandoned US trademark that was filed in 2024 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jan 29, 2024

SERIAL

79395335

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

CuraTeQ Biologics Private Limited

Entity

Not Provided

Address

Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City, Raidurg, Panmaktha, Hyderabad Telangana 500032

Country

Attorney

Law firm

CuraTeQ Biologics Private Limited

Address

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJan 29, 2024

Serial Number79395335

Registration No.0

Registration DateDec 31, 1969

Status DateApr 03, 2025

Mark TypeDesign with words

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

17 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 23, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 03, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

FINAL DISPOSITION NOTICE SENT TO IB

Apr 03, 2026

FINAL DISPOSITION NOTICE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Oct 24, 2025

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Oct 08, 2025

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Oct 08, 2025

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Apr 03, 2025

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Apr 03, 2025

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

REFUSAL PROCESSED BY IB

Sep 30, 2024

REFUSAL PROCESSED BY IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 04, 2024

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

REFUSAL PROCESSED BY MPU

Sep 04, 2024

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 04, 2024

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION WRITTEN

Sep 03, 2024

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Aug 22, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 15, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

May 15, 2024

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 09, 2024

SN ASSIGNED FOR SECT 66A APPL FROM IB

DAZUBLYS (TRASTUZUMAB)

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by CuraTeQ Biologics Private Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company